Lipidomic Analysis of Serum from High Fat Diet Induced Obese Mice

被引:118
作者
Eisinger, Kristina [1 ]
Liebisch, Gerhard [2 ]
Schmitz, Gerd [2 ]
Aslanidis, Charalampos [2 ]
Krautbauer, Sabrina [1 ]
Buechler, Christa [1 ]
机构
[1] Regensburg Univ Hosp, Dept Internal Med 1, D-93042 Regensburg, Germany
[2] Regensburg Univ Hosp, Inst Clin Chem & Lab Med, D-93042 Regensburg, Germany
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2014年 / 15卷 / 02期
关键词
phospholipids; lysophosphatidylcholine; lipidomic profiling; obesity; serum; HIGH-THROUGHPUT QUANTIFICATION; SPECTROMETRY ESI-MS/MS; INSULIN-RESISTANCE; MASS-SPECTROMETRY; CERAMIDE; PLASMA; CHOLESTEROL; PHOSPHATIDYLCHOLINE; ADIPOKINE; ACIDS;
D O I
10.3390/ijms15022991
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid metabolites regulate fatty acid and glucose homeostasis. The intention of the current study is to identify circulating lipid species, which are altered in rodent obesity and strongly correlate with the classically measured metabolites glucose, triglycerides, and cholesterol. Mice fed a high fat diet (HFD) for 14 weeks have increased body weight and fasting glucose. Serum triglycerides are not altered, while cholesterol tends to be increased. Accordingly, major cholesteryl ester (CE) species and free cholesterol are not significantly raised in obesity while minor metabolites, including CE 20:3 and CE 18:3, are increased or reduced, respectively. Distinct sphingomyelin (SM) species are elevated while ceramides are not raised. Phosphatidylinositol (PI) species, including PI 34:1, are raised while others are decreased. PI 34:1 strongly correlates with fasting glucose and proinsulin levels. Phosphatidylcholine (PC) 26:0, 40:2, and 40:5, which are induced in obesity, correlate with cholesterol. PC 38:4 and PC 40:6 are also raised in fat fed mice and positively correlate with fasting glucose. Lysophosphatidylcholine (LPC) species are also changed in obesity and the already shown reduction of LPC 16:1 has been confirmed. LPC 22:4, which is increased, correlates with serum cholesterol. The data indicate that circulating levels of various lipid species are changed in the obesity model studied and some of them are strongly associated with classically measured metabolites.
引用
收藏
页码:2991 / 3002
页数:12
相关论文
共 38 条
  • [1] High-Fat Diet Induces Dynamic Metabolic Alterations in Multiple Biological Matrices of Rats
    An, Yanpeng
    Xu, Wenxin
    Li, Huihui
    Lei, Hehua
    Zhang, Limin
    Hao, Fuhua
    Duan, Yixuan
    Yan, Xing
    Zhao, Ying
    Wu, Junfang
    Wang, Yulan
    Tang, Huiru
    [J]. JOURNAL OF PROTEOME RESEARCH, 2013, 12 (08) : 3755 - 3768
  • [2] Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes
    Barber, Melissa N.
    Risis, Steve
    Yang, Christine
    Meikle, Peter J.
    Staples, Margaret
    Febbraio, Mark A.
    Bruce, Clinton R.
    [J]. PLOS ONE, 2012, 7 (07):
  • [3] Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic Adipocytes
    Bauer, Sabrina
    Wanninger, Josef
    Schmidhofer, Sandra
    Weigert, Johanna
    Neumeier, Markus
    Dorn, Christoph
    Hellerbrand, Claus
    Zimara, Nicole
    Schaeffler, Andreas
    Aslanidis, Charalampos
    Buechler, Christa
    [J]. ENDOCRINOLOGY, 2011, 152 (01) : 26 - 35
  • [4] Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction
    Boden, G
    Shulman, GI
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 : 14 - 23
  • [5] Role of Sphingolipid Mediator Ceramide in Obesity and Renal Injury in Mice Fed a High-Fat Diet
    Boini, Krishna M.
    Zhang, Chun
    Xia, Min
    Poklis, Justin L.
    Li, Pin-Lan
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03) : 839 - 846
  • [6] Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance
    Boon, James
    Hoy, Andrew J.
    Stark, Romana
    Brown, Russell D.
    Meex, Ruth C.
    Henstridge, Darren C.
    Schenk, Simon
    Meikle, Peter J.
    Horowitz, Jeffrey F.
    Kingwell, Bronwyn A.
    Bruce, Clinton R.
    Watt, Matthew J.
    [J]. DIABETES, 2013, 62 (02) : 401 - 410
  • [7] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, Kiymet
    Bolton, Kristy
    McMillan, Janine
    Zimmet, Paul
    Jowett, Jeremy
    Collier, Greg
    Walder, Ken
    Segal, David
    [J]. ENDOCRINOLOGY, 2007, 148 (10) : 4687 - 4694
  • [8] Adiponectin, a key adipokine in obesity related liver diseases
    Buechler, Christa
    Wanninger, Josef
    Neumeier, Markus
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (23) : 2801 - 2811
  • [9] A Ceramide-Centric View of Insulin Resistance
    Chavez, Jose A.
    Summers, Scott A.
    [J]. CELL METABOLISM, 2012, 15 (05) : 585 - 594
  • [10] Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam
    Floegel, A.
    von Ruesten, A.
    Drogan, D.
    Schulze, M. B.
    Prehn, C.
    Adamski, J.
    Pischon, T.
    Boeing, H.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2013, 67 (10) : 1100 - 1108